61.94 USD
-0.83 (-1.32%)
Overall UTMD gets a fundamental rating of 6 out of 10. We evaluated UTMD against 186 industry peers in the Health Care Equipment & Supplies industry. UTMD gets an excellent profitability rating and is at the same time showing great financial health properties. UTMD has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- UTMD had positive earnings in the past year.
- UTMD had a positive operating cash flow in the past year.
- In the past 5 years UTMD has always been profitable.
- UTMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 9.53%, UTMD belongs to the top of the industry, outperforming 92.47% of the companies in the same industry.
- With an excellent Return On Equity value of 9.83%, UTMD belongs to the best of the industry, outperforming 86.56% of the companies in the same industry.
- UTMD has a Return On Invested Capital of 8.26%. This is amongst the best in the industry. UTMD outperforms 84.95% of its industry peers.
- UTMD had an Average Return On Invested Capital over the past 3 years of 12.32%. This is above the industry average of 8.84%.
- The 3 year average ROIC (12.32%) for UTMD is well above the current ROIC(8.26%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROIC | 8.26% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
1.3 Margins
- UTMD has a better Profit Margin (30.08%) than 97.31% of its industry peers.
- In the last couple of years the Profit Margin of UTMD has grown nicely.
- UTMD's Operating Margin of 30.78% is amongst the best of the industry. UTMD outperforms 97.85% of its industry peers.
- UTMD's Operating Margin has been stable in the last couple of years.
- UTMD has a Gross Margin (57.10%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of UTMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% |
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UTMD is still creating some value.
- Compared to 1 year ago, UTMD has less shares outstanding
- The number of shares outstanding for UTMD has been reduced compared to 5 years ago.
- There is no outstanding debt for UTMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 35.40 indicates that UTMD is not in any danger for bankruptcy at the moment.
- The Altman-Z score of UTMD (35.40) is better than 97.85% of its industry peers.
- There is no outstanding debt for UTMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 35.4 |
ROIC/WACC0.82
WACC10.05%
2.3 Liquidity
- UTMD has a Current Ratio of 32.06. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
- UTMD's Current ratio of 32.06 is amongst the best of the industry. UTMD outperforms 99.46% of its industry peers.
- UTMD has a Quick Ratio of 29.36. This indicates that UTMD is financially healthy and has no problem in meeting its short term obligations.
- UTMD's Quick ratio of 29.36 is amongst the best of the industry. UTMD outperforms 99.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 |
3. Growth
3.1 Past
- The earnings per share for UTMD have decreased strongly by -17.30% in the last year.
- UTMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.16% yearly.
- UTMD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.35%.
- UTMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.70% yearly.
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 17.50, which indicates a rather expensive current valuation of UTMD.
- 84.95% of the companies in the same industry are more expensive than UTMD, based on the Price/Earnings ratio.
- UTMD is valuated rather cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, UTMD is valued cheaply inside the industry as 95.70% of the companies are valued more expensively.
- 95.70% of the companies in the same industry are more expensive than UTMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.28 | ||
| EV/EBITDA | 7.87 |
4.3 Compensation for Growth
- The excellent profitability rating of UTMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)112.71
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- UTMD has a Yearly Dividend Yield of 2.06%.
- UTMD's Dividend Yield is rather good when compared to the industry average which is at 0.19. UTMD pays more dividend than 97.31% of the companies in the same industry.
- UTMD's Dividend Yield is comparable with the S&P500 average which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
5.2 History
- The dividend of UTMD has a limited annual growth rate of 1.95%.
- UTMD has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of UTMD decreased in the last 3 years.
Dividend Growth(5Y)1.95%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 34.80% of the earnings are spent on dividend by UTMD. This is a low number and sustainable payout ratio.
- UTMD's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.8%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:UTMD (1/22/2026, 3:31:01 PM)
61.94
-0.83 (-1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-28 2025-10-28
Earnings (Next)01-26 2026-01-26
Inst Owners70.35%
Inst Owner Change-0.19%
Ins Owners7.14%
Ins Owner Change-0.27%
Market Cap198.21M
Revenue(TTM)38.63M
Net Income(TTM)11.62M
Analysts0
Price TargetN/A
Short Float %3.25%
Short Ratio6.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
Yearly Dividend1.22
Dividend Growth(5Y)1.95%
DP34.8%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.5 | ||
| Fwd PE | N/A | ||
| P/S | 5.13 | ||
| P/FCF | 14.28 | ||
| P/OCF | 14.01 | ||
| P/B | 1.68 | ||
| P/tB | 1.93 | ||
| EV/EBITDA | 7.87 |
EPS(TTM)3.54
EY5.72%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.34
FCFY7%
OCF(TTM)4.42
OCFY7.14%
SpS12.07
BVpS36.95
TBVpS32.13
PEG (NY)N/A
PEG (5Y)112.71
Graham Number54.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.53% | ||
| ROE | 9.83% | ||
| ROCE | 9.99% | ||
| ROIC | 8.26% | ||
| ROICexc | 28.34% | ||
| ROICexgc | 51.06% | ||
| OM | 30.78% | ||
| PM (TTM) | 30.08% | ||
| GM | 57.1% | ||
| FCFM | 35.93% |
ROA(3y)12.3%
ROA(5y)11.87%
ROE(3y)13.06%
ROE(5y)12.7%
ROIC(3y)12.32%
ROIC(5y)12.29%
ROICexc(3y)38.7%
ROICexc(5y)33.39%
ROICexgc(3y)78.49%
ROICexgc(5y)75.65%
ROCE(3y)14.9%
ROCE(5y)14.86%
ROICexgc growth 3Y-5.7%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y5.77%
ROICexc growth 5Y9.65%
OM growth 3Y-0.06%
OM growth 5Y0.46%
PM growth 3Y4%
PM growth 5Y1.55%
GM growth 3Y-2.17%
GM growth 5Y-1.24%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 9.27% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 95.53% | ||
| Profit Quality | 119.44% | ||
| Current Ratio | 32.06 | ||
| Quick Ratio | 29.36 | ||
| Altman-Z | 35.4 |
F-Score6
WACC10.05%
ROIC/WACC0.82
Cap/Depr(3y)10.06%
Cap/Depr(5y)9.94%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.32%
Profit Quality(3y)119.58%
Profit Quality(5y)135.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-17.3%
EPS 3Y-0.66%
EPS 5Y0.16%
EPS Q2Q%-19.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-5.87%
Revenue growth 5Y-2.7%
Sales Q2Q%-1.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.61%
EBIT growth 3Y-5.93%
EBIT growth 5Y-2.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.02%
FCF growth 3Y-10.92%
FCF growth 5YN/A
OCF growth 1Y-37.46%
OCF growth 3Y-11.23%
OCF growth 5Y-2.76%
UTAH MEDICAL PRODUCTS INC / UTMD FAQ
What is the ChartMill fundamental rating of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTMD.
What is the valuation status of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
ChartMill assigns a valuation rating of 5 / 10 to UTAH MEDICAL PRODUCTS INC (UTMD). This can be considered as Fairly Valued.
How profitable is UTAH MEDICAL PRODUCTS INC (UTMD) stock?
UTAH MEDICAL PRODUCTS INC (UTMD) has a profitability rating of 8 / 10.
What are the PE and PB ratios of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
The Price/Earnings (PE) ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 17.5 and the Price/Book (PB) ratio is 1.68.
What is the financial health of UTAH MEDICAL PRODUCTS INC (UTMD) stock?
The financial health rating of UTAH MEDICAL PRODUCTS INC (UTMD) is 10 / 10.